What is Viekira Pak used for?
VIEKIRA PAK with or without ribavirin is indicated for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis.
Is Viekira Pak discontinued?
Discontinued. This treatment has been discontinued. On October 22, 2015 the United States FDA issued a Drug Safety Warning that treatment with ombitasvir- Page 1/7 Page 2 paritaprevir-ritonavir and dasabuvir (Viekira Pak) can cause serious liver injury, mostly in patients with underlying advanced liver disease.
How do you take Viekira?
Take 2 pink tablets plus 1 beige tablet at the same time every morning. Take 1 beige tablet at the same time every evening. The monthly Viekira XR or Viekira Pak carton contains enough tablets for you to take this medicine for 4 weeks (28 days in a row). You will need frequent blood tests to check your liver function.
Who makes Vosevi?
Vosevi (voh-SEV-ee) is a fixed dose combination of sofosbuvir and velpatasvir and voxilaprevir (Figure 1) and (Figure 2). It is manufactured by Gilead Sciences.
Who invented ribavirin?
Ribavirin was first discovered and developed in 1970 by researchers from the International Chemical & Nuclear Corporation (ICN), which is modernly known as Valeant Pharmaceuticals. Chemists Joseph T. Witkovski and Ronald K. Robins had a primary role in synthesizing this compound.
What is the brand name of ribavirin?
Ribavirin is an antiviral medication used together with an interferon alfa product (such as Peg-Intro or Intron A) to treat chronic hepatitis C. Ribavirin is available under the following different brand names: Rebetol, Ribasphere, RibaPak, Copegus, Virazole, and Moderiba.
Is Vosevi generic?
Vosevi is available only as a brand-name medication. It’s not currently available in generic form. Vosevi contains three active drug ingredients: sofosbuvir, velpatasvir, and voxilaprevir.
How effective is Vosevi?
HIGH CURE RATE In a clinical study, VOSEVI had a 96% overall cure rate in adult patients who had Hep C genotype 1, 2, 3, 4, 5, or 6 with just 12 weeks of therapy.
What was the first antiviral?
A new era of antiviral drug development has begun since the first antiviral drug, idoxuridine, was approved in June 1963 (3) (Fig. 1). Since then, many antiviral drugs have been developed for clinical use to treat millions of human beings worldwide.